Cargando…
Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847532/ https://www.ncbi.nlm.nih.gov/pubmed/33535106 http://dx.doi.org/10.1016/j.tmaid.2021.101981 |
| _version_ | 1783644941014007808 |
|---|---|
| author | De Wilton, Angus Nabarro, Laura E. Godbole, Gauri S. Chiodini, Peter L. Boyd, Aileen Woods, Katherine |
| author_facet | De Wilton, Angus Nabarro, Laura E. Godbole, Gauri S. Chiodini, Peter L. Boyd, Aileen Woods, Katherine |
| author_sort | De Wilton, Angus |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7847532 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78475322021-02-01 Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19 De Wilton, Angus Nabarro, Laura E. Godbole, Gauri S. Chiodini, Peter L. Boyd, Aileen Woods, Katherine Travel Med Infect Dis Correspondence Elsevier Ltd. 2021 2021-01-31 /pmc/articles/PMC7847532/ /pubmed/33535106 http://dx.doi.org/10.1016/j.tmaid.2021.101981 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence De Wilton, Angus Nabarro, Laura E. Godbole, Gauri S. Chiodini, Peter L. Boyd, Aileen Woods, Katherine Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19 |
| title | Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19 |
| title_full | Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19 |
| title_fullStr | Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19 |
| title_full_unstemmed | Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19 |
| title_short | Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19 |
| title_sort | risk of strongyloides hyperinfection syndrome when prescribing dexamethasone in severe covid-19 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847532/ https://www.ncbi.nlm.nih.gov/pubmed/33535106 http://dx.doi.org/10.1016/j.tmaid.2021.101981 |
| work_keys_str_mv | AT dewiltonangus riskofstrongyloideshyperinfectionsyndromewhenprescribingdexamethasoneinseverecovid19 AT nabarrolaurae riskofstrongyloideshyperinfectionsyndromewhenprescribingdexamethasoneinseverecovid19 AT godbolegauris riskofstrongyloideshyperinfectionsyndromewhenprescribingdexamethasoneinseverecovid19 AT chiodinipeterl riskofstrongyloideshyperinfectionsyndromewhenprescribingdexamethasoneinseverecovid19 AT boydaileen riskofstrongyloideshyperinfectionsyndromewhenprescribingdexamethasoneinseverecovid19 AT woodskatherine riskofstrongyloideshyperinfectionsyndromewhenprescribingdexamethasoneinseverecovid19 |